Table 1.

Patient characteristics and outcomes.

	All (n = 22)	ICUAW− (n = 2)†	ICUAW+ (n = 20)†	OR (95 % CI)	CIM− (n = 10)†	CIM+ (n = 12)†	OR (95 % CI)	CIM− ICUAW+ (n = 8)†
Age	61.10 (±10.17)	75.00 (±5.00)	59.70 (±9.48)	−-	60.20 (±10.40)	61.83 (±10.81)	−-	56.50 (±6.86)
Sex (male)	17/22, 77 %	1/2, 50 %	16/20, 80 %	−-	6/10, 60 %	11/12, 92 %	−-	5/8, 63 %
ICU stay (days)	15.55 (±5.61)	6.50 (±1.50)	16.45 (±5.05)	−-	12.80 (±5.14)	17.83 (±5.37)	−-	14.38 (±4.09)
Death in ICU	6/22, 27 %	0/2, 0 %	6/20, 30 %	2.24 (0.09–53.59)	0/10, 0 %	6/12, 50 %	21 (1.01–438.25)	0/8, 0 %
Death at 3 months	6/22, 27 %	0/2, 0 %	6/20, 30 %	1.56 (0.06–43.94)	0/10, 0 %	6/12, 50 %	20.09 (0.93–432.78)	0/8, 0 %

Note. Data are reported as mean (±standard deviation) or absolute numbers (percentages). ICUAW, intensive care unit acquired weakness; OR, odds ratio; CI, confidence interval; CIM, critical illness myopathy; ICU, intensive care unit.

^†The sample sizes of the different sub-groups refer to the total sample size of all included patients (n = 22).